Esperion Therapeutics, Inc.
ESPRDelisted Jul 13, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434868
Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Esperion Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 207
- +10 vs. Q4 2025
- Shares held
- 174.9M
- +38.6M (+28.3%) vs. Q4 2025
- Total value
- $479.3M
- −$25.0M (−5.0%) vs. Q4 2025
- New holders
- 41
- 65 more added
- Sold out
- 31
- 60 more reduced
4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ESPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 191 | $646.8M |
| Q1 2026 | 207 | $479.3M |
| Q4 2025 | 201 | $559.6M |
| Q3 2025 | 189 | $286.1M |
| Q2 2025 | 164 | $96.6M |
| Q1 2025 | 187 | $171.5M |
| Q4 2024 | 190 | $277.9M |
| Q3 2024 | 184 | $214.3M |
| Q2 2024 | 176 | $304.2M |
| Q1 2024 | 152 | $336.2M |
| Q4 2023 | 132 | $215.3M |
| Q3 2023 | 123 | $75.9M |
| Q2 2023 | 124 | $103.6M |
| Q1 2023 | 165 | $129.1M |
| Q4 2022 | 164 | $457.6M |
| Q3 2022 | 148 | $425.5M |
| Q2 2022 | 137 | $352.1M |
| Q1 2022 | 132 | $241.2M |
| Q4 2021 | 133 | $268.0M |
| Q3 2021 | 139 | $299.4M |
| Q2 2021 | 142 | $599.4M |
| Q1 2021 | 156 | $805.3M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Esperion Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 7,075,083 | $19.4M | 0.02% | +1,603,472+29.3% | Added |
| Two Sigma Investments, LP | 9,458,779 | $25.9M | 0.02% | +4,716,697+99.5% | Added |
| Vanguard Capital Management LLC | 10,433,760 | $28.6M | 0.00% | +10,433,760 | New |
| OrbiMed Advisors LLC | 10,570,300 | $29.0M | 0.66% | +4,604,802+77.2% | Added |
| Two Seas Capital LP | 11,394,833 | $31.2M | 1.44% | −507,688−4.3% | Reduced |
| Wasatch Advisors Inc | 15,768,897 | $43.2M | 0.29% | +6,323,138+66.9% | Added |
| BlackRock, Inc. | 17,852,427 | $48.9M | 0.00% | +170,226+1.0% | Added |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −3,505,200−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −259,563−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −244,292−100.0% | Sold out |
| Polen Capital Management LLC | 0 | $0 | 0.00% | −116,292−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −75,238−100.0% | Sold out |
| Integrated Quantitative Investments LLC | 0 | $0 | 0.00% | −72,249−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −67,450−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −66,890−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −67,751−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −51,800−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −34,815−100.0% | Sold out |
| PSI Advisors, LLC | 0 | $0 | 0.00% | −22,344−100.0% | Sold out |
| MML Investors Services, LLC | 0 | $0 | 0.00% | −21,511−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −15,173−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −14,050−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −12,549−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −12,050−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Cary Street Partners Financial LLC | 0 | $0 | 0.00% | −10,175−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −9,570−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −7,350−100.0% | Sold out |
| Laurel Wealth Advisors LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,716−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −650−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Innovative Advisory Group, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Sunbelt Securities, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Pandora Wealth, Inc. | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |